JANIE FLEMING: Open Payments
NPI 1821682881 · NAVARRE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,319 in 73 payments from 15 companies in 2025. Trend: 2023 $263 · 2024 $843 · 2025 $1,319
Food & beverage: $1,319
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $390 |
| Novo Nordisk Inc | 13 | $177 |
| ABBVIE INC. | 10 | $162 |
| Axsome Therapeutics, Inc. | 5 | $114 |
| Lilly USA, LLC | 7 | $110 |
| PFIZER INC. | 5 | $95 |
| Corium, LLC | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Supernus Pharmaceuticals, Inc. | 2 | $28 |
Products named: AIRSUPRA, FARXIGA, MOUNJARO, NURTEC ODT, Ozempic, QULIPTA, Wegovy, Azstarys.
Industry payments across FL — which companies pay providers there.
